Decision Support
Compare Products
Side-by-side comparison of 2–3 reviewed products. Empty cells mean the manufacturer has not published that value — we show what sources support, nothing more.
Filled with competing tests for the same target from other manufacturers, where the catalogue has them — swap any column with the picker above.
| Field | Elecsys AFP | LDH 21 FS | Seraseq Tri-Level Tumor Mutation DNA Mix v2 HC |
|---|---|---|---|
| Manufacturer | Roche Diagnostics | DiaSys Diagnostic Systems | LGC SeraCare Life Sciences |
| Category | Immunoassay & Serology / Tumor Markers | Clinical Chemistry / General Chemistry | Sequencing & Genomics |
| Technology | Chemiluminescence Immunoassay | Ion-Selective / Clinical Chemistry | Next-Generation Sequencing |
| Regulatory status | Not disclosed | Not disclosed | RUO |
| Verified | 2026-10-26 | 2026-10-20 | 2026-10-17 |
| Linked registration records | 0 record(s) | 0 record(s) | 0 record(s) |
| Source | Official page | Official page | Official page |
| Next step | Request quote | Request quote | Request quote |
Comparisons use manufacturer-published specifications and our editorial review; registration claims are counted from linked regulatory records only.